EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Friday 13 Jun, 12:00 PM - 12:00 PM Glasgow, United Kingdom